[go: up one dir, main page]

Xue et al., 2023 - Google Patents

A comprehensive review of nanoparticles for oral delivery in food: biological fate, evaluation models, and gut microbiota influences

Xue et al., 2023

View HTML
Document ID
3929139684783326117
Author
Xue J
Blesso C
Luo Y
Publication year
Publication venue
Annual Review of Food Science and Technology

External Links

Snippet

Edible nanoparticles are being developed for the oral delivery of nutrients to improve human health and well-being. Because of the extremely demanding conditions foods experience within the gastrointestinal tract, fundamental knowledge about the biological fate of …
Continue reading at www.annualreviews.org (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application

Similar Documents

Publication Publication Date Title
Dima et al. Bioavailability and bioaccessibility of food bioactive compounds; overview and assessment by in vitro methods
Vitulo et al. Interactions between nanoparticles and intestine
Xue et al. A comprehensive review of nanoparticles for oral delivery in food: biological fate, evaluation models, and gut microbiota influences
Iravani et al. Plant-derived edible nanoparticles and miRNAs: emerging frontier for therapeutics and targeted drug-delivery
Durazzo et al. An updated overview on nanonutraceuticals: Focus on nanoprebiotics and nanoprobiotics
Ozkan et al. Effects of lipid-based encapsulation on the bioaccessibility and bioavailability of phenolic compounds
Zheng et al. Formulation of more efficacious curcumin delivery systems using colloid science: enhanced solubility, stability, and bioavailability
Zhao et al. Dual-core prebiotic microcapsule encapsulating probiotics for metabolic syndrome
De Anda-Flores et al. Polysaccharide-based nanoparticles for colon-targeted drug delivery systems
Mu et al. Effect of long-term intake of dietary titanium dioxide nanoparticles on intestine inflammation in mice
Yao et al. Improved functionality of Ligilactobacillus salivarius Li01 in alleviating colonic inflammation by layer-by-layer microencapsulation
Abbasi et al. Potential in vivo delivery routes of postbiotics
de Vos et al. Encapsulation for preservation of functionality and targeted delivery of bioactive food components
Keen et al. Encapsulation of lactic acid bacteria in colloidosomes
Wen et al. Encapsulation of phycocyanin by prebiotics and polysaccharides-based electrospun fibers and improved colon cancer prevention effects
Haung et al. A novel oral astaxanthin nanoemulsion from Haematococcus pluvialis induces apoptosis in lung metastatic melanoma
EP3352773B1 (en) Antibacterial and protective bacteriophage formulations and methods for making and using them
Reiner et al. Extracellular vesicles as vehicles for the delivery of food bioactives
Garcia-Brand et al. Novel developments on stimuli-responsive probiotic encapsulates: from smart hydrogels to nanostructured platforms
Huang et al. Experimental chemotherapy-induced mucositis: a scoping review guiding the design of suitable preclinical models
Kuang et al. Triggerable prodrug nanocoating enables on-demand activation of microbial and small-molecular therapeutics for combination treatment
Hu et al. Influence of tripolyphosphate cross-linking on the physical stability and lipase digestibility of chitosan-coated lipid droplets
Iriarte-Mesa et al. Morphology-Dependent Interaction of silica nanoparticles with intestinal cells: connecting shape to barrier function
Colaço et al. Safe-by-design of glucan nanoparticles: size matters when assessing the immunotoxicity
Mishra et al. Caffeic acid-conjugated budesonide-loaded nanomicelle attenuates inflammation in experimental colitis